VistaGen Therapeutics Company
VistaGen is a biopharmaceutical company developing innovative product candidates for patients with diseases and disorders involving the CNS.
Technology:
Stem cell therapy
Industry:
Public
Headquarters:
San Francisco, California, United States
Founded Date:
1998-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Total Funding:
54750281
Estimated Revenue:
$1M to $10M
Last Funding Date:
2016-06-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership